Yakov Datsenko
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Hepatitis C virus research 6
-
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Steven J. Padula (2 shared papers)Pentti A. Järvinen (1 shared paper)Sudha Visvanathan (1 shared paper)Alan M. Solinger (1 shared paper)Dominique Baeten (1 shared paper)Tae‐Hwan Kim (1 shared paper)Lai‐Shan Tam (1 shared paper)Chandrasena Pamulapati (1 shared paper)
- Journals
- Journal of Hepatology (4 papers)Hepatology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Dermatology and Therapy (1 paper)BMJ Open (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Yakov Datsenko
11 papers receiving 616 citations
Yakov Datsenko's Hit Papers
Peers
Comparison fields: 5 of 33
- Hepatology 254
- Rheumatology 280
- Immunology 238
- Hematology 115
- Dermatology 52
Countries citing papers authored by Yakov Datsenko
This map shows the geographic impact of Yakov Datsenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yakov Datsenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yakov Datsenko more than expected).
Fields of papers citing papers by Yakov Datsenko
This network shows the impact of papers produced by Yakov Datsenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yakov Datsenko. The network helps show where Yakov Datsenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Yakov Datsenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study Hit paper breakdown → | 2018 | 293 |
| 2 | 2013 | 91 | |
| 3 | 2021 | 68 | |
| 4 | 2013 | 62 | |
| 5 | 2013 | 29 | |
| 6 | 2011 | 29 | |
| 7 | 2011 | 25 | |
| 8 | 2010 | 15 | |
| 9 | 2014 | 10 | |
| 10 | 2012 | 4 | |
| 11 | 2023 | 1 |
About Yakov Datsenko
Yakov Datsenko is a scholar working on Hepatology, Immunology, Genetics, Epidemiology and Rheumatology, having authored 11 papers that have together received 627 indexed citations. Recurring topics across this work include Hepatitis C virus research (6 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hepatitis B Virus Studies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Spondyloarthritis Studies and Treatments (1 paper), HIV/AIDS drug development and treatment (1 paper), Ethics in Clinical Research (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Hepatology (254 citations), Rheumatology (280 citations), Immunology (238 citations), Hematology (115 citations) and Dermatology (52 citations). Yakov Datsenko has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Steven J. Padula, Pentti A. Järvinen, Sudha Visvanathan, Alan M. Solinger, Dominique Baeten, Tae‐Hwan Kim, Lai‐Shan Tam, Chandrasena Pamulapati, David B. Hall and Mikkel Østergaard. Their work appears in journals such as Journal of Hepatology, Hepatology, Antimicrobial Agents and Chemotherapy, Dermatology and Therapy and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.